25 results
8-K
EX-99.1
MYMD
MyMD Pharmaceuticals Inc
3 Aug 23
MyMD Pharmaceuticals Phase 2 Trial Update
4:30pm
, a scientific leader and cutting edge developer at the forefront of innovation. Our flagship product is the next generation TNF-α inhibitor, uniquely designed
424B4
rauck9e rct6d
9 Dec 19
Prospectus supplement with pricing info
6:08am
8-K
rev36e54l 77tj
7 Dec 18
Entry into a Material Definitive Agreement
5:15pm
424B5
4pvkk669edyb79fq
2 Nov 18
Prospectus supplement for primary offering
6:13am
424B4
799jf4uz zi3paayh7v
20 Dec 17
Prospectus supplement with pricing info
12:00am